Home › Funds › AJU IB Investment Co., Ltd. › XLO
AJU IB Investment Co., Ltd. position in XLO
XILIO THERAPEUTICS INC · Health Care
AJU IB Investment Co., Ltd. reported holding 47,695 shares of XLO (XILIO THERAPEUTICS INC) in its Q1 2026 13F filing — a position valued at US$401K, representing 1.31% of its reported portfolio and ranking #6 among its reported holdings. AJU IB Investment Co., Ltd. has disclosed XLO holdings in 6 of the last 6 reported quarters, going back to Q4 2024.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How AJU IB Investment Co., Ltd.'s XLO position evolved
AJU IB Investment Co., Ltd. first disclosed a stake in XLO in Q4 2024 at 667,742 shares (US$638K). Across 6 filings, AJU IB Investment Co., Ltd. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q1 2026) shows 47,695 shares valued at US$401K — a reduction of -620,047 shares quarter over quarter.. Notable position changes include a 93% trim in Q1 2026 (shares rose 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 667.74K | $637.69K | New |
| Q1 2025 | 667.74K | $483.71K | Hold |
| Q2 2025 | 667.74K | $454.00K | Hold |
| Q3 2025 | 667.74K | $595.56K | Hold |
| Q4 2025 | 667.74K | $427.49K | Hold |
| Q1 2026 | 47.70K | $401.12K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About XLO and 13F data
XLO (XILIO THERAPEUTICS INC) is a Health Care company. 24 other funds we track also report a position in XLO — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$6.4M), GILEAD SCIENCES, INC. (US$6.2M), Frazier Life Sciences Management, L.P. (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding XLO
- Bain Capital Life Sciences Investors, LLC 664.02K sh · $6.36M · Q2 2026
- GILEAD SCIENCES, INC. 650.39K sh · $6.23M · Q2 2026
- Frazier Life Sciences Management, L.P. 422.50K sh · $4.05M · Q2 2026
- Stonepine Capital Management, LLC 225.99K sh · $2.17M · Q2 2026
- Sio Capital Management, LLC 152.46K sh · $1.46M · Q2 2026
- Merck & Co., Inc. 105.98K sh · $1.02M · Q2 2026
- Velan Capital Investment Management LP 14.29K sh · $136.85K · Q2 2026
More on AJU IB Investment Co., Ltd.
FAQ
How long has AJU IB Investment Co., Ltd. held XLO?
AJU IB Investment Co., Ltd. has disclosed XLO holdings in 6 of the last 6 reported quarters, going back to Q4 2024.
What is AJU IB Investment Co., Ltd.'s current position in XLO?
As of Q1 2026, AJU IB Investment Co., Ltd. holds 47.70K shares of XLO (XILIO THERAPEUTICS INC), valued at $401.12K, representing 1.31% of its reported portfolio and ranking #6.
Has AJU IB Investment Co., Ltd. been buying or selling XLO?
In the latest 13F filing (Q1 2026), AJU IB Investment Co., Ltd. reduced its position in XLO.
Which other funds hold XLO?
Other major institutional holders of XLO include Bain Capital Life Sciences Investors, LLC, GILEAD SCIENCES, INC., Frazier Life Sciences Management, L.P., among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.